2022
DOI: 10.1016/j.cca.2022.03.026
|View full text |Cite
|
Sign up to set email alerts
|

Biochemical, molecular, and clinical features of patients with glutaric acidemia type 1 identified through large-scale newborn screening in Zhejiang Province, China

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(8 citation statements)
references
References 23 publications
0
7
1
Order By: Relevance
“…In this study, 18 patients with GA1 were identified via 1.15 million NBS results, and the incidence was approximately 1 in 63,948 births in Fujian Province. This incidence is much higher than that in Zhejiang Province (1:221,053) [ 18 ] and Jining City (1:171,411) in eastern China [ 20 ].…”
Section: Discussionmentioning
confidence: 91%
See 3 more Smart Citations
“…In this study, 18 patients with GA1 were identified via 1.15 million NBS results, and the incidence was approximately 1 in 63,948 births in Fujian Province. This incidence is much higher than that in Zhejiang Province (1:221,053) [ 18 ] and Jining City (1:171,411) in eastern China [ 20 ].…”
Section: Discussionmentioning
confidence: 91%
“…Early detection and timely intervention for inborn metabolic disorders through NBS are crucial for preventing adverse clinical symptoms in affected individuals. With the widespread application of MS/MS, GC/MS, and NGS, patients with GA1 have been diagnosed timely [ 18 , 23 , 24 ]. The estimated prevalence of GA1 varies widely depending on race and region, ranging from 1:125,000 to 1:250 newborns [ 25 29 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…As shown in Table 4 , the GCDH c.1261G > A [p.(Ala421Thr)] variant was detected in 4 Chinese GAI patients, namely GAI-054, GAI-091, GAI-093, and GAI-094, all combined with c.1244-2 A > C (homozygous in GAI-054). GAI-054, GAI-093, and GAI-094 were identified by NBS [ 12 , 13 ], while GAI-091 were identified by a clinical exome sequencing cohort for developmental disorders [ 14 ]. Pedigree analysis was clear only in GAI-091 (c.1244-2 A > C from father and c.1261G > A from mother).…”
Section: Resultsmentioning
confidence: 99%